Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 8, 2010
Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines
Gerhard Sattler, Michael J Callander, Doris Grablowitz, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 7, 2022
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Said Hilton, Philippe Kestemont, Gerhard Sattler, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 29, 2019
Safe, Effective Chin and Jaw Restoration With VYC-25L Hyaluronic Acid Injectable Gel
Patricia Ogilvie, Gerhard Sattler, Frodo Gaymans, et al.
Journal of Drugs in Dermatology : JDD
|
May 9, 2022
Calcium Hydroxyapatite Filler With Integral Lidocaine CaHA (+) for Soft Tissue Augmentation: Results from an Open-Label Multicenter Clinical Study
Tatjana Pavicic, Gerhard Sattler, Tanja Fischer, et al.
Clinical, Cosmetic and Investigational Dermatology
|
September 5, 2020
Safety and Performance of Etermis 3 and 4 in Wrinkles/Folds Treatment and Facial Volume Enhancement: A Prospective, Evaluator-Blinded, Open-Label Study
Gerhard Sattler, Martina Kerscher, Ernst Magnus Noah, et al.
Journal of Drugs in Dermatology : JDD
|
February 5, 2013
Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications
Berthold Rzany, Alina A M Fratila, Tanja C Fischer, et al.
Journal of Cosmetic Dermatology
|
February 7, 2022
The subjectively perceived injectability as an early indicator for adverse events?
Michael G Alfertshofer, Gerhard Sattler, Konstantin Frank, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
February 7, 2017
A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months
Gerhard Sattler, Wolfgang G Philipp-Dormston, Helga Van Den Elzen, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 17, 2020
IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study
Patrick Trevidic, Simon A Connolly, Bernard Biwer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 11, 2018
Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines
Koenraad De Boulle, William Philip Werschler, Michael H Gold, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 8, 2010
Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines
Gerhard Sattler, Michael J Callander, Doris Grablowitz, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 7, 2022
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Said Hilton, Philippe Kestemont, Gerhard Sattler, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 29, 2019
Safe, Effective Chin and Jaw Restoration With VYC-25L Hyaluronic Acid Injectable Gel
Patricia Ogilvie, Gerhard Sattler, Frodo Gaymans, et al.
Journal of Drugs in Dermatology : JDD
|
May 9, 2022
Calcium Hydroxyapatite Filler With Integral Lidocaine CaHA (+) for Soft Tissue Augmentation: Results from an Open-Label Multicenter Clinical Study
Tatjana Pavicic, Gerhard Sattler, Tanja Fischer, et al.
Clinical, Cosmetic and Investigational Dermatology
|
September 5, 2020
Safety and Performance of Etermis 3 and 4 in Wrinkles/Folds Treatment and Facial Volume Enhancement: A Prospective, Evaluator-Blinded, Open-Label Study
Gerhard Sattler, Martina Kerscher, Ernst Magnus Noah, et al.
Journal of Drugs in Dermatology : JDD
|
February 5, 2013
Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications
Berthold Rzany, Alina A M Fratila, Tanja C Fischer, et al.
Journal of Cosmetic Dermatology
|
February 7, 2022
The subjectively perceived injectability as an early indicator for adverse events?
Michael G Alfertshofer, Gerhard Sattler, Konstantin Frank, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
February 7, 2017
A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months
Gerhard Sattler, Wolfgang G Philipp-Dormston, Helga Van Den Elzen, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 17, 2020
IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study
Patrick Trevidic, Simon A Connolly, Bernard Biwer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
August 11, 2018
Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines
Koenraad De Boulle, William Philip Werschler, Michael H Gold, et al.
Page
of 7